BD 2142215 - PowerLoc MAX PAK Safety Infusion Set, 22G x 1.5", Without Y-Injection Site", 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2142215 - PowerLoc MAX PAK Safety Infusion Set, 22G x 1.5", Without Y-Injection Site", 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2142215 PowerLoc MAX PAK Safety Infusion Set is a sterile, single-use port-access solution designed for accessing compatible subcutaneously implanted vascular ports. The set features a 22-gauge non-coring needle with a 1.5-inch length and is configured without a Y-injection site.

The PowerLoc MAX system provides a fluid pathway for administering compatible medications and solutions, withdrawing blood specimens, flushing implanted ports, and delivering contrast media through appropriately rated power-injectable ports. The 22-gauge configuration offers a smaller needle profile for therapies and procedures that do not require the higher flow capability of a larger-gauge access device.

The 1.5-inch needle length is intended for implanted ports located beneath a greater depth of subcutaneous tissue. Careful needle-length selection helps clinicians achieve secure port septum access while maintaining appropriate positioning and dressing stability.

An integrated safety mechanism is housed within the needle base. During port deaccessing, the needle is withdrawn through the base so that the bevel becomes covered and locked within the protective housing. This single-step activation is designed to help reduce accidental needlestick exposure during needle removal, handling, transportation, and disposal.

The low-profile, wingless design supports dressing application and routine access-site management. A stable padded footprint is designed to promote patient comfort, while the rotating needle hub allows the tubing to be positioned according to the treatment environment and dressing configuration.

The MAX PAK presentation provides an organized solution intended to simplify the multi-step sterile port-access preparation process. BD 2142215 is supplied five sets per case.

Key Benefits

• 22-gauge non-coring needle supports access to compatible implanted vascular ports.
• Smaller needle diameter may be appropriate when moderate flow capability meets the requirements of the prescribed therapy.
• 1.5-inch needle length accommodates ports located beneath greater subcutaneous tissue depth.
• Power-injectable design supports compatible contrast-enhanced imaging procedures.
• Supports power-injection flow rates up to 2 mL per second when the complete system is properly rated.
• Integrated safety mechanism covers and locks the needle bevel following removal.
• Single-step safety activation helps reduce accidental needlestick exposure.
• Low-profile base supports secure dressing placement and access-site care.
• Wingless construction helps minimize unnecessary bulk beneath the dressing.
• Padded, stable footprint is designed to support patient comfort during port access.
• Rotating needle hub supports convenient tubing positioning and maneuverability.
• Dual-lumen port compatibility supports appropriate specialized port configurations.
• Configuration without a Y-injection site provides a direct fluid pathway.
• MAX PAK presentation helps organize supplies used during sterile port-access preparation.
• Five-per-case packaging supports controlled clinical inventory management.

Compatibility and Applications

The BD 2142215 PowerLoc MAX PAK Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, long-term infusion therapy, blood specimen collection, port flushing, blood product administration, and contrast-media delivery during compatible diagnostic imaging procedures.

The 22-gauge needle may be selected when the prescribed medication, solution viscosity, desired flow rate, and implanted port specifications permit the use of a smaller-gauge access device. Clinical teams should confirm that the 22-gauge configuration provides sufficient performance for the intended procedure.

Compatible 22-gauge PowerLoc MAX configurations support power-injection flow rates up to 2 mL per second under approved operating conditions. The actual permitted rate may be lower depending on the implanted port, connectors, tubing, power injector, contrast medium, and other components within the fluid pathway.

The 1.5-inch length is intended for deeper implanted ports or patients with greater tissue depth over the port septum. A needle that is too short may not enter the septum completely, while an unnecessarily long needle may affect stability, securement, and dressing placement.

The set is supplied without a Y-injection site. It may be appropriate for workflows that use a direct tubing connection and do not require a secondary medication or injection-access point.

Compatibility should be confirmed with the implanted port model, septum design, port depth, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access procedures.

Usage Guidelines

The BD 2142215 should be used only by healthcare professionals who are trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status.
• Assess the location and depth of the implanted port before selecting the 1.5-inch needle.
• Verify that the 22-gauge configuration provides sufficient flow capability for the intended procedure.
• Inspect the sterile package for punctures, moisture, damage, contamination, or compromised integrity.
• Prepare the port-access site using the antiseptic procedure required by institutional policy.
• Prime the infusion set completely with an approved solution using aseptic technique.
• Remove air from the tubing and fluid pathway before accessing the implanted port.
• Stabilize the port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate contact with the base of the port reservoir is achieved.
• Verify correct placement according to institutional policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and facility protocol.
• Position the rotating hub and tubing to minimize pulling, twisting, pressure, and dressing disruption.
• Secure the access device and apply an approved sterile dressing.
• Monitor the site for pain, swelling, redness, leakage, displacement, or other complications.
• Confirm power-injection eligibility before connecting the set to a power injector.
• Do not exceed 2 mL per second or the lower operating limit of any connected component.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and activating the safety mechanism.
• Confirm that the needle bevel is completely covered and locked within the protective base.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the port-access system if resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, or another abnormality develops at the access site.

Certifications and Safety Standards

The BD 2142215 PowerLoc MAX PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The device should be incorporated into facility procedures covering implanted port assessment, aseptic access, infusion administration, securement, dressing management, power injection, port deaccessing, and sharps disposal.

The integrated safety mechanism supports occupational exposure-control procedures by covering and locking the needle bevel following removal. This safety feature does not replace appropriate clinician training, personal protective equipment, careful sharps handling, or immediate disposal in an approved sharps container.

The non-coring needle is designed to access the septum of a compatible implanted vascular port while helping minimize unnecessary septum damage. The needle gauge and length must be selected according to the implanted port, patient anatomy, prescribed therapy, and current manufacturer instructions.

Healthcare organizations should review current manufacturer documentation for applicable FDA clearance, UDI information, sterilization method, shelf life, material composition, natural rubber latex status, DEHP information, pressure limits, flow-rate specifications, and other technical or regulatory requirements.

Comparison with Competitors

Compared with conventional port-access needles without integrated safety features, the BD PowerLoc MAX includes a mechanism that covers and locks the needle bevel during deaccessing. This can help reduce accidental needlestick exposure between needle removal and final sharps disposal.

Compared with winged non-coring needle sets, the wingless and low-profile PowerLoc MAX base may simplify dressing placement and improve access-site management. Winged alternatives may remain preferable when clinicians require wings for insertion control or stabilization.

Compared with non-power-injectable port-access sets, the PowerLoc MAX supports compatible power-injection procedures when used with an approved power-injectable port and within all specified pressure and flow limits.

Compared with sets containing a Y-injection site, BD 2142215 provides a direct fluid pathway without an additional secondary access point. This may reduce unnecessary connections when secondary medication administration is not required.

Compared with 19-gauge and 20-gauge configurations, the 22-gauge needle provides a smaller external diameter but a lower maximum power-injection flow rate. The best gauge should be selected according to the required therapy, fluid viscosity, desired flow, port specifications, and clinical judgment.

Compared with 0.75-inch and 1-inch needle options, the 1.5-inch configuration accommodates ports positioned beneath greater tissue depth. Accurate depth assessment is important because using an unnecessarily long needle may affect device stability and dressing application.

Competing safety infusion sets may vary in gauge, needle length, power-injection capability, safety activation method, base profile, padding, tubing design, Y-site configuration, included preparation components, and packaging quantity. The BD 2142215 combines a 22-gauge, 1.5-inch non-coring needle with an integrated safety mechanism, low-profile padded base, and direct tubing configuration.

Typical User Profile and Application Scenarios

The BD 2142215 PowerLoc MAX PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other healthcare facilities where implanted vascular ports are routinely accessed.

The product may be selected for patients whose implanted port depth requires a 1.5-inch access needle and whose prescribed therapy or diagnostic procedure is compatible with a 22-gauge device.

Typical application scenarios include medication infusion, antibiotic therapy, hydration, selected chemotherapy protocols, blood specimen collection, port maintenance, parenteral nutrition, and power injection of contrast media at compatible flow rates.

The configuration without a Y-injection site is particularly relevant when a direct connection is preferred and the treatment plan does not require secondary access through the infusion tubing.

Best Practices for Use and Maintenance

The BD 2142215 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on correct storage, product selection, sterile preparation, port-access technique, site monitoring, safety activation, and disposal.

• Store unopened sets under the environmental conditions specified by the manufacturer.
• Protect packages from moisture, excessive heat, freezing, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2142215 catalog number before opening the package.
• Confirm the 22-gauge size, 1.5-inch length, and absence of a Y-injection site.
• Assess the patient's tissue depth and implanted port position before selecting the needle length.
• Confirm that the required therapy and flow rate are appropriate for a 22-gauge device.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the tubing completely before connecting it to the implanted port.
• Stabilize the port during both needle insertion and removal.
• Use the rotating hub to position the tubing without creating tension at the access site.
• Monitor the site throughout therapy for infiltration, extravasation, infection, leakage, or displacement.
• Verify the power-injectable status of the complete access system before a powered procedure.
• Never exceed the lowest pressure or flow-rate limit of any connected component.
• Do not bend, cut, modify, repair, or otherwise alter the device.
• Do not reuse, clean, resterilize, or reprocess the single-use set.
• Verify complete safety activation immediately after needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2142215 PowerLoc MAX PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 22-gauge size, 1.5-inch needle length, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every connected component are specifically identified as power injectable. The permitted pressure, flow rate, contrast-media viscosity, and other operating conditions must be verified before beginning the procedure.

Compatible 22-gauge PowerLoc MAX configurations support power-injection flow rates up to 2 mL per second when used under manufacturer-specified conditions. The lowest-rated component within the complete system determines the maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may cause infiltration, extravasation, leakage, tissue injury, port damage, interrupted treatment, or other complications.

Because this model does not include a Y-injection site, it does not provide a secondary medication-access point within the tubing. Clinical teams should confirm that the direct configuration is suitable for the intended procedure before opening the package.

The integrated safety mechanism should be activated according to current manufacturer instructions. The used device remains a contaminated sharp even after the needle bevel is covered and must be discarded immediately in an approved sharps container.

The product is supplied five sets per case. Distributor listings identify this configuration as temperature sensitive and non-returnable. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, order quantity, and return conditions before purchasing.

How to Order

Select the BD 2142215 - PowerLoc MAX PAK Safety Infusion Set without Y-Injection Site, 22G x 1.5" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.